Arterial input function (AIF), also known as a plasma input function, refers to the concentration of tracer in blood-plasma in an artery measured over time. The oldest record on PubMed shows that AIF was used by Harvey et al. [1] in 1962 to measure the exchange of materials between red blood cells and blood plasma, and by other researchers in 1983 for positron emission tomography (PET) studies. [2] [3] Nowadays, kinetic analysis is performed in various medical imaging techniques, which requires an AIF as one of the inputs to the mathematical model, for example, in dynamic PET imaging, [4] or perfusion CT, [5] or dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI). [6] [7]
AIF can be obtained in several different ways, for example, using the invasive method of continuous arterial sampling using an online blood monitor, [8] using the invasive method of arterial blood samples obtained at discrete time points post-injection, [4] using a minimally invasive method using a population-based AIF where an input function in a subject is estimated partly from the prior information obtained from a previous population and partly from the blood information from the subject itself obtained at the time of scanning, [9] or using an image-derived arterial input function (IDAIF) obtained by placing a region of interest (ROI) over an artery and calibrating the resulting curves against venous blood samples obtained during the later phases (30 to 60 minutes) of the dynamic scan [10] when venous and arterial tracer concentrations become equal. [4]
A dynamic scan is a scan where two dimensional (2D) or three dimensional (3D) images are acquired again and again over a time-period forming a time-series of 2D/3D image datasets. For example, a dynamic PET scan acquired over a period of one hour contains the first few short image frames acquired for 5 seconds duration to capture the fast dynamics of the tracer immediately after a tracer-injection and later frames acquired for 30 seconds. Each data-point in the AIF curve represents a measurement of tracer-concentration from an artery obtained from each of these image time-frame acquired over time, with external corrections applied to it.[ citation needed ]
These four methods are briefly described as follows:
Continuous arterial blood sampling is invasive, painful, and uncomfortable for the patients. Continuous arterial sampling was obtained in postmenopausal women imaged using [18F]NaF for bone studies. [11]
Discrete arterial blood sampling is invasive, painful, and uncomfortable for the patients. Cook et al. measured discrete blood samples and compared them to continuous arterial sampling in postmenopausal women imaged using [18F]NaF for bone studies. [11] Another study in head and neck cancer patients imaged using [18F]FLT PET, and numerous other studies, obtained discrete arterial samples for the estimation of arterial input function. [12]
The approach of obtaining discrete arterial sampling was based on the observation that the bolus peak occurs with 5 minutes after injection, and that the latter part of the curve, in most cases, represent a single or bi-exponential curve. It implied that continuous arterial sampling was not necessary, and the discrete arterial blood samples were enough to obtain the continuous curves using an exponential model fit.[ citation needed ]
A population-based input function generally relies on the dataset previously obtained by other researchers in a specific set of populations, and average values are used. The methods generally provide better results if a large number of datasets is used and based on the assumption that the input function in a new patient in this sub-group of the population will be insignificantly different from the population average values. In a neuroinflammation study, the author using a population-based input function in healthy volunteers and liver-transplanted patients imaged using [18F]GE-180 PET. [13] In another study, healthy controls and patients with Parkinson's and Alzheimer's disease were imaged using [18F]FEPPA PET. [14] Zanotti-Fregonara et al. [15] thoroughly reviewed the literature on the arterial input function used for brain PET imaging and suggested the possibility of population-based arterial input functions as a potential alternative to invasive arterial sampling. [ citation needed ]
However, Blake et al. [16] derived a semi-population based method from healthy postmenopausal women imaged using [18F]NaF for bone studies [16] based on the observation that the later part of the arterial input function can be constructed from the venous blood samples, as the venous and arterial blood concentration of tracer is equal 30 minutes after the injection. They derived the peak of the curve from a previous study that obtained continuous arterial sampling, and the later part of the curve from the venous blood samples of the individual patient in whom an AIF is to be estimated. When combined, a semi-population based arterial input function is obtained as a result.[ citation needed ]
An image-derived arterial input function (IDAIF) obtained by measuring the tracer counts over the aorta, [4] carodit artery, [17] or radial artery [8] offers an alternative to invasive arterial blood sampling. An IDAIF at the aorta can be determined by measuring the tracer counts over the left ventricle, ascending aorta, and abdominal aorta and this has been previously validated by various researchers. [10] [4]
The arterial time-activity curve (TAC) from the image data requires corrections for metabolites formed over time, differences between whole blood and plasma activity, which are not constant over time, correction for partial volume errors (PVE) due to the small size of the ROI, spill-over errors due to activity from neighbouring tissues outside the ROI, [18] error due to patient movement, and noise introduced due to the limited number of counts acquired in each image time frame because of the short time frames. These errors are corrected using late venous blood samples, [4] [10] and the resulting curve is called an arterial input function (AIF). There are numerous methods tried by researchers over the years. [19] [20] [21] [22]
Positron emission tomography (PET) is a functional imaging technique that uses radioactive substances known as radiotracers to visualize and measure changes in metabolic processes, and in other physiological activities including blood flow, regional chemical composition, and absorption. Different tracers are used for various imaging purposes, depending on the target process within the body. For example, 18
F
-FDG is commonly used to detect cancer, NaF18
F
is widely used for detecting bone formation, and oxygen-15 is sometimes used to measure blood flow.
Single-photon emission computed tomography is a nuclear medicine tomographic imaging technique using gamma rays. It is very similar to conventional nuclear medicine planar imaging using a gamma camera, but is able to provide true 3D information. This information is typically presented as cross-sectional slices through the patient, but can be freely reformatted or manipulated as required.
Nuclear medicine or nucleology is a medical specialty involving the application of radioactive substances in the diagnosis and treatment of disease. Nuclear imaging, in a sense, is "radiology done inside out" because it records radiation emitting from within the body rather than radiation that is generated by external sources like X-rays. In addition, nuclear medicine scans differ from radiology, as the emphasis is not on imaging anatomy, but on the function. For such reason, it is called a physiological imaging modality. Single photon emission computed tomography (SPECT) and positron emission tomography (PET) scans are the two most common imaging modalities in nuclear medicine.
Perfusion is the passage of fluid through the circulatory system or lymphatic system to an organ or a tissue, usually referring to the delivery of blood to a capillary bed in tissue. Perfusion is measured as the rate at which blood is delivered to tissue, or volume of blood per unit time per unit tissue mass. The SI unit is m3/(s·kg), although for human organs perfusion is typically reported in ml/min/g. The word is derived from the French verb "perfuser" meaning to "pour over or through". All animal tissues require an adequate blood supply for health and life. Poor perfusion (malperfusion), that is, ischemia, causes health problems, as seen in cardiovascular disease, including coronary artery disease, cerebrovascular disease, peripheral artery disease, and many other conditions.
A bone scan or bone scintigraphy is a nuclear medicine imaging technique of the bone. It can help diagnose a number of bone conditions, including cancer of the bone or metastasis, location of bone inflammation and fractures, and bone infection (osteomyelitis).
Neuroimaging is the use of quantitative (computational) techniques to study the structure and function of the central nervous system, developed as an objective way of scientifically studying the healthy human brain in a non-invasive manner. Increasingly it is also being used for quantitative studies of brain disease and psychiatric illness. Neuroimaging is a highly multidisciplinary research field and is not a medical specialty.
Fluorine-18 (18F) is a fluorine radioisotope which is an important source of positrons. It has a mass of 18.0009380(6) u and its half-life is 109.771(20) minutes. It decays by positron emission 96% of the time and electron capture 4% of the time. Both modes of decay yield stable oxygen-18.
In pharmacokinetics and receptor-ligand kinetics the binding potential (BP) is a combined measure of the density of "available" neuroreceptors and the affinity of a drug to that neuroreceptor.
Functional imaging is a medical imaging technique of detecting or measuring changes in metabolism, blood flow, regional chemical composition, and absorption.
Myocardial perfusion imaging or scanning is a nuclear medicine procedure that illustrates the function of the heart muscle (myocardium).
Perfusion is the passage of fluid through the lymphatic system or blood vessels to an organ or a tissue. The practice of perfusion scanning is the process by which this perfusion can be observed, recorded and quantified. The term perfusion scanning encompasses a wide range of medical imaging modalities.
Nuclear medicine physicians, also called nuclear radiologists or simply nucleologists, are medical specialists that use tracers, usually radiopharmaceuticals, for diagnosis and therapy. Nuclear medicine procedures are the major clinical applications of molecular imaging and molecular therapy. In the United States, nuclear medicine physicians are certified by the American Board of Nuclear Medicine and the American Osteopathic Board of Nuclear Medicine.
Rubidium-82 (82Rb) is a radioactive isotope of rubidium. 82Rb is widely used in myocardial perfusion imaging. This isotope undergoes rapid uptake by myocardiocytes, which makes it a valuable tool for identifying myocardial ischemia in Positron Emission Tomography (PET) imaging. 82Rb is used in the pharmaceutical industry and is marketed as Rubidium-82 chloride under the trade names RUBY-FILL and CardioGen-82.
Cardiac imaging refers to non-invasive imaging of the heart using ultrasound, magnetic resonance imaging (MRI), computed tomography (CT), or nuclear medicine (NM) imaging with PET or SPECT. These cardiac techniques are otherwise referred to as echocardiography, Cardiac MRI, Cardiac CT, Cardiac PET and Cardiac SPECT including myocardial perfusion imaging.
Brain positron emission tomography is a form of positron emission tomography (PET) that is used to measure brain metabolism and the distribution of exogenous radiolabeled chemical agents throughout the brain. PET measures emissions from radioactively labeled metabolically active chemicals that have been injected into the bloodstream. The emission data from brain PET are computer-processed to produce multi-dimensional images of the distribution of the chemicals throughout the brain.
Fallypride is a high affinity dopamine D2/D3 receptor antagonist used in medical research, usually in the form of fallypride (18F) as a positron emission tomography (PET) radiotracer in human studies.
PET radiotracer is a type of radioligand that is used for the diagnostic purposes via positron emission tomography imaging technique.
Cerebral blood volume is the blood volume in a given amount of brain tissue.
In medical imaging, a time-activity curve is a curve of radioactivity plotted on the y-axis against the time plotted on the x-axis. It shows the concentration of a radiotracer within a region of interest in an image, measured over time from a dynamic scan. Generally, when a time-activity curve is obtained within a tissue, it is called as a tissue time-activity curve, which represents the concentration of tracer within a region of interest inside a tissue over time.
Positron emission tomography for bone imaging, as an in vivo tracer technique, allows the measurement of the regional concentration of radioactivity proportional to the image pixel values averaged over a region of interest (ROI) in bones. Positron emission tomography is a functional imaging technique that uses [18F]NaF radiotracer to visualise and quantify regional bone metabolism and blood flow. [18F]NaF has been used for imaging bones for the last 60 years. This article focuses on the pharmacokinetics of [18F]NaF in bones, and various semi-quantitative and quantitative methods for quantifying regional bone metabolism using [18F]NaF PET images.